Related references
Note: Only part of the references are listed.Ghrelin and motilin receptors as drug targets for gastrointestinal disorders
Gareth J. Sanger et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference
Oleg Otlivanchik et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19
Lauren M. Stein et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells
Mollisa M. Elrick et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
The expanding repertoire of receptor activity modifying protein (RAMP) function
Klara R. Klein et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme
M. Yu et al.
DIABETES OBESITY & METABOLISM (2016)
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study
M. Odawara et al.
DIABETES OBESITY & METABOLISM (2016)
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research
Zhixiang Wang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models
Dan-yang Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naive patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial
Michael Roden et al.
CARDIOVASCULAR DIABETOLOGY (2015)
GPR40 agonists for the treatment of type 2 diabetes: life after 'TAKing' a hit
A. D. Mancini et al.
DIABETES OBESITY & METABOLISM (2015)
Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
K. Kaku et al.
DIABETES OBESITY & METABOLISM (2015)
C-peptide: New findings and therapeutic possibilities
John Wahren et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
A 9-Month Toxicity and Toxicokinetic Assessment of Subcutaneous Pegylated Human C-peptide (CBX129801) in Cynomolgus Monkeys
Dennis Naas et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2015)
Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes
Jin Ook Chung et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Jesper Lau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Five-Year Efficacy and Safety Data of Exenatide Once Weekly: Long-term Results From the DURATION-1 Randomized Clinical Trial
Carol H. Wysham et al.
MAYO CLINIC PROCEEDINGS (2015)
The Physiology of Proinsulin C-Peptide: Unanswered Questions and a Proposed Model
Gina L. C. Yosten et al.
PHYSIOLOGY (2015)
Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study
Nobuya Inagaki et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
Maria Hauge et al.
MOLECULAR METABOLISM (2015)
Physiological effects and therapeutic potential of proinsulin C-peptide
Gina L. C. Yosten et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin
Jennifer P. Richards et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
Efficacy and Safety of Vildagliptin in New-Onset Diabetes After Kidney Transplantation-A Randomized, Double-Blind, Placebo-Controlled Trial
M. Haidinger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR
Nigel A. Chapman et al.
BIOCHEMISTRY AND CELL BIOLOGY (2014)
Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice
Young-Cheol Lim et al.
CARDIOVASCULAR RESEARCH (2014)
Efficacy and Safety of Linagliptin in Subjects With Long-standing Type 2 Diabetes Mellitus (>10 Years): Evidence From Pooled Data of Randomized, Double-blind, Placebo-controlled, Phase III Trials
Rosemarie Lajara et al.
CLINICAL THERAPEUTICS (2014)
Recent developments in biased agonism
James W. Wisler et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
John M. Lachin et al.
DIABETES (2014)
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)
C. Mathieu et al.
DIABETES OBESITY & METABOLISM (2014)
Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naive patients with type 2 diabetes: a randomized, double-blind, 6-month study
R. E. Pratley et al.
DIABETES OBESITY & METABOLISM (2014)
The retinal pigment epithelium: An important player of retinal disorders and regeneration
Chikafumi Chiba
EXPERIMENTAL EYE RESEARCH (2014)
Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation
Elizabeth E. Capowski et al.
HUMAN MOLECULAR GENETICS (2014)
Increased Glucose Metabolism and Glycerolipid Formation by Fatty Acids and GPR40 Receptor Signaling Underlies the Fatty Acid Potentiation of Insulin Secretion
Mahmoud El-Azzouny et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)
Julio Rosenstock et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
Ankita Srivastava et al.
NATURE (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
Kyoko Kudo-Fujimaki et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Cell Models to Study Regulation of Cell Transformation in Pathologies of Retinal Pigment Epithelium
Alla V. Kuznetsova et al.
JOURNAL OF OPHTHALMOLOGY (2014)
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
Richard E. Pratley et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes
Jennifer P. Richards et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
G Protein-Coupled Receptor Deorphanizations
Olivier Civelli et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian-Rui Xu et al.
CELLULAR SIGNALLING (2013)
C-Peptide Activates AMPKα and Prevents ROS-Mediated Mitochondrial Fission and Endothelial Apoptosis in Diabetes
Mahendra Prasad Bhatt et al.
DIABETES (2013)
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
Michael A. Nauck
DIABETES CARE (2013)
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
Peter C. Butler et al.
DIABETES CARE (2013)
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)
Matthew C. Riddle et al.
DIABETES CARE (2013)
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) inpatients with type 2 diabetes
S. J. Yang et al.
DIABETES OBESITY & METABOLISM (2013)
Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P)
M. Pinget et al.
DIABETES OBESITY & METABOLISM (2013)
LIRAGLUTIDE AS ADDITIONAL TREATMENT TO INSULIN IN OBESE PATIENTS WITH TYPE 1 DIABETES MELLITUS
Nitesh D. Kuhadiya et al.
ENDOCRINE PRACTICE (2013)
Regulation of Na,K-ATPase β1-subunit in TGF-β2-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells
Sridevi Mony et al.
EXPERIMENTAL EYE RESEARCH (2013)
Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors
Sudarshan Rajagopal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Evidence for an interaction between proinsulin C-peptide and GPR146
Gina L. C. Yosten et al.
JOURNAL OF ENDOCRINOLOGY (2013)
DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic β-Cells Dysfunction in db/db Mice
Peng Sun et al.
PLOS ONE (2013)
Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins
Heather E. Moad et al.
PROTEIN SCIENCE (2013)
Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage
A. Moses
BMJ-British Medical Journal (2013)
DIABETES DRUGS Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?
Deborah Cohen
BMJ-BRITISH MEDICAL JOURNAL (2013)
Evidence for an interaction of neuronostatin with the orphan G protein-coupled receptor, GPR107
Gina L. C. Yosten et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Molecular Mechanism of beta-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Eric Reiter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Inside-out, outside-in, and inside-outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction
Bo Shen et al.
CURRENT OPINION IN CELL BIOLOGY (2012)
The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
John Wahren et al.
DIABETES (2012)
Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment Results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
Itamar Raz et al.
DIABETES CARE (2012)
Vildagliptin Added to Metformin on β-Cell Function After a Euglycemic Hyperinsulinemic and Hyperglycemic Clamp in Type 2 Diabetes Patients
Giuseppe Derosa et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1
M. Ferdaoussi et al.
DIABETOLOGIA (2012)
Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes
Marta Busnelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Biased Agonism of the Angiotensin II Type 1 Receptor
C. M. Godin et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
Charles F. Burant et al.
LANCET (2012)
A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
Jian Luo et al.
PLOS ONE (2012)
Ghrelin Expression in the Mouse Pancreas Defines a Unique Multipotent Progenitor Population
Luis Arnes et al.
PLOS ONE (2012)
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
Ralph A. DeFronzo
DIABETES CARE (2011)
Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells
Ralf Schroeder et al.
NATURE PROTOCOLS (2011)
C-peptide and long-term complications of diabetes
Patrizia Luppi et al.
PEDIATRIC DIABETES (2011)
Human Amniotic Fluid Promotes Retinal Pigmented Epithelial Cells' Trans-Differentiation into Rod Photoreceptors and Retinal Ganglion Cells
Shima Ghaderi et al.
STEM CELLS AND DEVELOPMENT (2011)
TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats
Yoshiyuki Tsujihata et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats
Xiaodong Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Dimerization in GPCR mobility and signaling
Martin J. Lohse
CURRENT OPINION IN PHARMACOLOGY (2010)
Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
J. Michael Gaziano et al.
DIABETES CARE (2010)
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes
E. J. Rhee et al.
DIABETES OBESITY & METABOLISM (2010)
Regulation of G-Protein Signaling by RKTG via Sequestration of the G beta gamma Subunit to the Golgi Apparatus
Yuhui Jiang et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The Tight Junction Associated Signalling Proteins ZO-1 and ZONAB Regulate Retinal Pigment Epithelium Homeostasis in Mice
Anastasios Georgiadis et al.
PLOS ONE (2010)
Epithelial-Mesenchymal Transition and Proliferation of Retinal Pigment Epithelial Cells Initiated upon Loss of Cell-Cell Contact
Shigeo Tamiya et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Deletion of GPR40 Impairs Glucose-Induced Insulin Secretion In Vivo in Mice Without Affecting Intracellular Fuel Metabolism in Islets
Thierry Alquier et al.
DIABETES (2009)
Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins
Zhanxiang Wang et al.
JOURNAL OF CELL SCIENCE (2009)
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Bo Ahren
NATURE REVIEWS DRUG DISCOVERY (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Pharmacokinetics, Pharmacodynamics, and Tolerability of the Dipeptidyl Peptidase IV Inhibitor LC15-0444 in Healthy Korean Men: A Dose-Block-Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose, Phase I Study
Kyoung Soo Lim et al.
CLINICAL THERAPEUTICS (2008)
Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion
Sara Edfalk et al.
DIABETES (2008)
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes
J. Rosenstock et al.
DIABETES OBESITY & METABOLISM (2008)
Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization
Roberto Vettor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
VEGF modulation of retinal pigment epithelium resistance
Zsolt Ablonczy et al.
EXPERIMENTAL EYE RESEARCH (2007)
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: Importance of fatty acid length, polarity, and bulkiness
Kjeld Madsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Identification of residues important for agonist recognition and activation in GPR40
Chi Shing Sum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
K. Hermansen et al.
DIABETES OBESITY & METABOLISM (2007)
Seven transmembrane receptors: something old, something new
R. J. Lefkowitz
ACTA PHYSIOLOGICA (2007)
GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo
Martin G. Latour et al.
DIABETES (2007)
Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the Calcitonin receptor-like receptor gene
RT Dackor et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The retinal pigment epithelium in visual function
O Strauss
PHYSIOLOGICAL REVIEWS (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
Transdifferentiation of the retinal pigment epithelia to the neural retina by transfer of the Pax6 transcriptional factor
N Azuma et al.
HUMAN MOLECULAR GENETICS (2005)
The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse
R Steneberg et al.
CELL METABOLISM (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb
M Tsimaratos et al.
DIABETOLOGIA (2003)
Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors
M Flahaut et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Molecular basis for the insulinomimetic effects of C-peptide
G Grunberger et al.
DIABETOLOGIA (2001)
Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts
M Henriksson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
β-Arrestin 2:: A receptor-regulated MAPK scaffold for the activation of JNK3
PH McDonald et al.
SCIENCE (2000)
Bromocriptine - A novel approach to the treatment of type 2 diabetes
H Pijl et al.
DIABETES CARE (2000)
The hypocretin/orexin story
WK Samson et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
Share Paper
